Spots Global Cancer Trial Database for chemokine receptor type 5 (ccr5)
Every month we try and update this database with for chemokine receptor type 5 (ccr5) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046) | NCT03631407 | Colorectal Neop... | Vicriviroc Pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC |